Akèy › Maladi otoim › Kentucky › Louisville
Etid klinik pou Maladi otoim nan Louisville, KY
6 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Louisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- University Of Louisville Brown Cancer Center, Louisville
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Norton Cancer Institute, St. Matthews Campus, Louisville
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- University Of Louisville Brown Cancer Center, Louisville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- University of Louisville Hospital - James Brown Cancer Center, Louisville
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Ap rekriteFaz 1
- University of Louisville, Louisville
VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
Ap rekrite
- Norton Healthcare, Louisville
- University of Louisville, Louisville
Etid Maladi otoim nan lòt vil
- Houston, TX21 etid
- Washington, DC19 etid
- New York City, NY19 etid
- Philadelphia, PA16 etid
- Durham, NC15 etid
- Boston, MA13 etid
- Chicago, IL12 etid
- Los Angeles, CA12 etid
- Dallas, TX9 etid
- Atlanta, GA8 etid
- Portland, OR8 etid
- Milwaukee, WI8 etid
Lòt etid nan Louisville
- Kansè Poumon ki pa ti selil22 etid
- Obèsite17 etid
- Sipwa15 etid
- Kansè (tout kalite)14 etid
- Ensifizyans kadyak13 etid
- Leksemi mieloïd egi12 etid
- Myelom Miltip12 etid
- Kansè ovè12 etid
- Kansè nan tete11 etid
- Karsinòm selil skuamèz tèt ak kou11 etid
- Kansè poumon11 etid
- Melanom10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.